We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBU icon
1926
Community Bank
CBU
$3.37B
$1.56M ﹤0.01%
23,629
-933
-4% -$59.8K
ZNGA
1927
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$1.55M ﹤0.01%
+253,744
New +$1.5M
ATRI
1928
DELISTED
Atrion Corp
ATRI
$1.55M ﹤0.01%
1,817
+63
+4% +$55.7K
BSJK
1929
DELISTED
Invesco BulletShares 2020 High Yield Corporate Bond ETF
BSJK
$1.55M ﹤0.01%
64,490
-25,233
-28% -$607K
KTB icon
1930
Kontoor Brands
KTB
$4.27B
$1.55M ﹤0.01%
+55,228
New +$1.64M
KNX icon
1931
Knight Transportation
KNX
$11.2B
$1.54M ﹤0.01%
46,958
-2,276
-5% -$72.6K
ARCH
1932
DELISTED
Arch Resources, Inc.
ARCH
$1.54M ﹤0.01%
16,352
+489
+3% +$44.8K
GNRC icon
1933
Generac Holdings
GNRC
$12.2B
$1.54M ﹤0.01%
22,192
+14,123
+175% +$825K
KL
1934
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$1.54M ﹤0.01%
35,753
-64,839
-64% -$2.25M
JBLU icon
1935
JetBlue
JBLU
$2.13B
$1.53M ﹤0.01%
82,923
+43,840
+112% +$784K
TEF
1936
DELISTED
Telefonica
TEF
$1.53M ﹤0.01%
228,874
-20,520
-8% -$136K
CARS icon
1937
Cars.com
CARS
$653M
$1.53M ﹤0.01%
77,471
+2,880
+4% +$61.6K
JHMD icon
1938
John Hancock Multifactor Developed International ETF
JHMD
$985M
$1.53M ﹤0.01%
54,089
-6,060
-10% -$171K
WEN icon
1939
Wendy's
WEN
$1.39B
$1.53M ﹤0.01%
78,044
+7,329
+10% +$138K
PXH icon
1940
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.98B
$1.52M ﹤0.01%
70,526
-313,157
-82% -$6.66M
GDS icon
1941
GDS Holdings
GDS
$6.29B
$1.52M ﹤0.01%
40,432
-1,558
-4% -$56.7K
SUPN icon
1942
Supernus Pharmaceuticals
SUPN
$2.74B
$1.51M ﹤0.01%
45,743
+2,271
+5% +$77.8K
NI icon
1943
NiSource
NI
$20B
$1.51M ﹤0.01%
52,388
-2,333
-4% -$65.7K
EVN
1944
Eaton Vance Municipal Income Trust
EVN
$429M
$1.5M ﹤0.01%
121,016
-80,980
-40% -$988K
SEE
1945
DELISTED
Sealed Air
SEE
$1.5M ﹤0.01%
35,169
-33,630
-49% -$1.48M
AJRD
1946
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$1.5M ﹤0.01%
33,624
-3,479
-9% -$130K
AVAV icon
1947
AeroVironment
AVAV
$9.57B
$1.5M ﹤0.01%
26,434
+1,171
+5% +$77.1K
BCV
1948
Bancroft Fund
BCV
$140M
$1.5M ﹤0.01%
67,015
+1,575
+2% +$33.9K
AU icon
1949
AngloGold Ashanti
AU
$49.2B
$1.5M ﹤0.01%
84,142
-84,961
-50% -$1.14M
EPP icon
1950
iShares MSCI Pacific ex Japan ETF
EPP
$2.26B
$1.5M ﹤0.01%
31,708
+1,127
+4% +$52.2K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.